Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 11 min ago
Peer-reviewedCC BY 4.0Frontiers in Endocrinology

Intramyocellular lipid droplet–mitochondria uncoupling drives muscle atrophy via metabolite-directed epigenetic reprogramming: a review

  • Lingfeng Wu1
  • Ye Wang2
  • Kailian Ma3
  • Yang Liu4
4 affiliations
  1. 1School of Acupuncture-Moxibustion and Tuina, Changchun University of Chinese Medicine
  2. 2Department of Pain Management, Affiliated Hospital of Changchun University of Chinese Medicine
  3. 3Department of Nephrology, Affiliated Hospital of Changchun University of Chinese Medicine
  4. 4Department of Acupuncture and Moxibustion, Affiliated Hospital of Changchun University of Chinese Medicine
Read full textPDFDOICite

Abstract

Type 2 diabetes mellitus (T2DM)-associated sarcopenia is driven by protein degradation and impaired myogenic regeneration. While classical models emphasize cytosolic kinase pathways, the subcellular mechanisms mediating lipotoxicity-induced chronic catabolism remain incompletely understood. This review elucidates a tripartite pathological cascade comprising organelle structural uncoupling, metabolic intermediate overflow, and epigenetic reprogramming. Chronic intramyocellular lipid accumulation disrupts lipid droplet–mitochondria contact (LDMC) sites, largely via Mfn2 modification. This spatial dissociation impairs mitochondrial oxidation, driving the nucleocytoplasmic accumulation of polar metabolites, specifically Acetyl-CoA, succinate, and lactate. Acting as covalent substrates or competitive inhibitors, these metabolites modulate histone-modifying enzymes such as p300/CBP and JmjC-domain demethylases. Consequently, this substrate-driven epigenetic remodeling increases chromatin accessibility at E3 ubiquitin ligase promoters ( Atrogin-1 , MuRF1 ) and concurrently represses myogenic loci ( MyoD , MyoG ), locking the tissue in a catabolic transcriptional state. Effective interventions must target this organelle-metabolite-epigenetic axis. Beyond systemic agents like SGLT2 inhibitors and GLP-1 receptor agonists, precision strategies—including repairing LDMC topology, bypassing enzymatic bottlenecks via CPT1 or LDHA, and restoring epigenetic homeostasis—are necessary to preserve lean mass and maintain skeletal muscle under metabolic stress.

Related

  1. Reprogramming the gut–brain axis in neurodegeneration: comparative microbiome, metabolite, immunometabolic, polyphenol, probiotic, and epigenetic mechanisms in Alzheimer’s and Parkinson’s diseases
    Yu Jie Cheng, Mei Ping Tao, Kexin Qian +1
    Frontiers in Aging NeurosciencePeer-reviewedCC BYFull textMolecular biology & gene regulationDOAJ
  2. Microbiome-mitochondria crosstalk in neuro-oncology: molecular mechanisms, immunometabolic reprogramming, and therapeutic opportunities
    Debabrata Dash, Muskan Rajak, Priyanka Manothiya +1
    Frontiers in MicrobiomesPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMC
  3. Epigenetic Landscape and Regulation of Secondary Metabolite Accumulation Implicated in Anticancer and Nutraceuticals.
    Deekshitha Kosaraju, Viswanadha Naik Jarapala, Aparna Yeddala +5
    EpigenomesPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  4. Histone modifications in laryngeal squamous cell carcinoma: from epigenetic reprogramming to precision therapy
    Zexi Lv, Qiuping Li, Xiaodong Feng
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefEurope PMC
  5. Epigenetic and 3D genome reprogramming during the aging of the human hippocampus
    Nathan R. Zemke, Seo Yeon Lee, Sainath Mamde +23
    SciencePeer-reviewedCC BY28 citedMolecular biology & gene regulationOpenAlex

Cite

BibTeXRIS
BibTeX
@article{wu2026intramyocellular,
  title = {{Intramyocellular lipid droplet–mitochondria uncoupling drives muscle atrophy via metabolite-directed epigenetic reprogramming: a review}},
  author = {Lingfeng Wu and Ye Wang and Kailian Ma and Yang Liu},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  month = oct,
  doi = {10.3389/fendo.2026.1980958},
  url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1980958/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Intramyocellular lipid droplet–mitochondria uncoupling drives muscle atrophy via metabolite-directed epigenetic reprogramming: a review
AU  - Lingfeng Wu
AU  - Ye Wang
AU  - Kailian Ma
AU  - Yang Liu
PY  - 2026
DA  - 2026/10/13
JO  - Frontiers in Endocrinology
DO  - 10.3389/fendo.2026.1980958
UR  - https://www.frontiersin.org/articles/10.3389/fendo.2026.1980958/full
AB  - Type 2 diabetes mellitus (T2DM)-associated sarcopenia is driven by protein degradation and impaired myogenic regeneration. While classical models emphasize cytosolic kinase pathways, the subcellular mechanisms mediating lipotoxicity-induced chronic catabolism remain incompletely understood. This review elucidates a tripartite pathological cascade comprising organelle structural uncoupling, metabolic intermediate overflow, and epigenetic reprogramming. Chronic intramyocellular lipid accumulation disrupts lipid droplet–mitochondria contact (LDMC) sites, largely via Mfn2 modification. This spatial dissociation impairs mitochondrial oxidation, driving the nucleocytoplasmic accumulation of polar metabolites, specifically Acetyl-CoA, succinate, and lactate. Acting as covalent substrates or competitive inhibitors, these metabolites modulate histone-modifying enzymes such as p300/CBP and JmjC-domain demethylases. Consequently, this substrate-driven epigenetic remodeling increases chromatin accessibility at E3 ubiquitin ligase promoters ( Atrogin-1 , MuRF1 ) and concurrently represses myogenic loci ( MyoD , MyoG ), locking the tissue in a catabolic transcriptional state. Effective interventions must target this organelle-metabolite-epigenetic axis. Beyond systemic agents like SGLT2 inhibitors and GLP-1 receptor agonists, precision strategies—including repairing LDMC topology, bypassing enzymatic bottlenecks via CPT1 or LDHA, and restoring epigenetic homeostasis—are necessary to preserve lean mass and maintain skeletal muscle under metabolic stress.
SN  - 1664-2392
ER  -